Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN 203818 in female patients with fibromyalgia syndrome
2006-006100-11Phase 2Completed
- Sponsor
- Allergan
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing AGN 203818 arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy measurement. Started Mar 2007; status: completed.
02
Drugs
rezatomidine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2006-006100-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006100-11.